Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L)’s Pliant Therapeutics PLRX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$652K	Buy	517,453 +145,502	+39%	+$184K	﹤0.01%	1260
2025 Q4	$454K	Buy	371,951 +347,611	+1,428%	+$522K	﹤0.01%	1324
2025 Q3	$36K	Buy	+24,340	New	+$37.1K	﹤0.01%	1471
2024 Q4	–	Sell	-34,611	Closed	-$388K	–	1589
2024 Q3	$388K	Buy	+34,611	New	+$433K	﹤0.01%	1160
2023 Q2	–	Sell	-43,479	Closed	-$1.16M	–	1454
2023 Q1	$1.16M	Buy	+43,479	New	+$1.24M	0.01%	677

Other funds holding PLRX

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Monaco Asset Management Monaco $315M AUM 54.4% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return